Cite
APA Citation
Canovatchel, W., Thayer, S., Chow, W., Qiu, R., Davies, M., & Fegade, M. (n.d.). efficacy of canagliflozin (CANA) versus dipeptidyl peptidase-4 inhibitors (DPP-4i) in patients with T2DM: Results from RCTs and Real-World (RW) study. Diabetes research and clinical practice, 120, S118–. http://access.bl.uk/ark:/81055/vdc_100039989173.0x00003f